First-in-class antifibrotic therapy targeting type 1 lysophosphatidic acid receptor
Author:
- 30 June 2012
- journal article
- other
- Published by Springer Nature in Archives of Pharmacal Research
- Vol. 35 (6) , 945-948
Abstract
Fibrosis is a normal process for repairing injured tissue. However, aberrant or hyperfibrotic responses result in serious pathologic conditions and sometimes life-threatening diseases. A new class of drugs antagonizing type 1 lysophosphatidic acid receptor has been developed and is under investigation in clinical trials for the treatment of idiopathic pulmonary fibrosis and systemic fibrosis or scleroderma. This will be the first drug in its class to target G-protein-coupled receptors for lysophosphatidic acid.Keywords
This publication has 19 references indexed in Scilit:
- Pharmacokinetic and Pharmacodynamic Characterization of an Oral Lysophosphatidic Acid Type 1 Receptor-Selective AntagonistThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of sclerodermaArthritis & Rheumatism, 2011
- International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid Receptor NomenclaturePharmacological Reviews, 2010
- Lysophosphatidic acid-activated Cl- current activity in human systemic sclerosis skin fibroblastsRheumatology, 2010
- A novel, orally active LPA 1 receptor antagonist inhibits lung fibrosis in the mouse bleomycin modelBritish Journal of Pharmacology, 2010
- LPA Receptors: Subtypes and Biological ActionsAnnual Review of Pharmacology and Toxicology, 2010
- LPA1 Receptor Activation Promotes Renal Interstitial FibrosisJournal of the American Society of Nephrology, 2007
- Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severityLife Sciences, 2007
- International Union of Pharmacology. XXXIV. Lysophospholipid Receptor NomenclaturePharmacological Reviews, 2002
- Lysophosphatidate-induced cell proliferation: Identification and dissection of signaling pathways mediated by G proteinsCell, 1989